Novartis AG (LON:0QLR)
93.53
+0.48 (0.52%)
At close: Aug 8, 2025
Exscientia Market Cap
Novartis AG has a market cap or net worth of 170.56 billion as of August 12, 2025. Its market cap has increased by 0.85% in one year.
Market Cap
170.56B
Enterprise Value
189.51B
Revenue
40.28B
Ranking
n/a
PE Ratio
17.11
Stock Price
$93.53
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 77.31B to 170.56B, an increase of 120.61%. That is a compound annual growth rate of 2.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 170.56B | 9.16% |
Dec 30, 2024 | 156.24B | -3.94% |
Dec 29, 2023 | 162.64B | 0.78% |
Dec 30, 2022 | 161.38B | 10.87% |
Dec 30, 2021 | 145.56B | -8.09% |
Dec 30, 2020 | 158.37B | -3.22% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 171.13B |
HSBC Holdings | 164.50B |
Shell | 155.20B |
Unilever | 112.26B |
British American Tobacco p.l.c. | 92.38B |
Rolls-Royce Holdings | 90.11B |
Rio Tinto Group | 77.80B |
RELX PLC | 65.52B |